660923652	660923652	CD	B-NP	O
|	|	NNP	I-NP	O
JH	JH	NNP	I-NP	O
|	|	VBD	B-VP	O
49613363	49613363	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
690360	690360	CD	B-NP	O
|	|	CC	I-NP	O
2/6/1996	2/6/1996	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/29/1996	5/29/1996	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/16/1996	4/16/1996	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
NON	NON	NNP	B-NP	O
Q	Q	NNP	I-NP	O
WAVE	WAVE	NNP	I-NP	O
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	O
INFARCTION	INFARCTION	NNP	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
53-year-old	53-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
mental	mental	JJ	I-NP	O
retardation	retardation	NN	I-NP	O
,	,	,	O	O
schizophrenia	schizophrenia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
borderline	borderline	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
Himend	Himend	NNP	B-NP	O
Richdent	Richdent	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Services	Service	NNPS	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
non	non	JJ	I-NP	B-DNA
Q	Q	NN	I-NP	I-DNA
wave	wave	VBP	B-VP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
August	August	NNP	B-NP	O
1995	1995	CD	I-NP	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
family	family	NN	I-NP	O
reports	report	NNS	I-NP	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
intermittent	intermittent	JJ	B-NP	B-protein
abdominal	abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
worsen	worsen	VB	I-VP	O
until	until	IN	B-PP	O
October	October	NNP	B-NP	O
1996	1996	CD	I-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
medical	medical	JJ	I-NP	O
doctor	doctor	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
and	and	CC	O	O
Theo-Dur	Theo-Dur	NNP	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
noticed	notice	VBD	B-VP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
increasing	increase	VBG	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
lethargy	lethargy	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
now	now	RB	B-ADVP	O
significant	significant	JJ	B-NP	O
weight	weight	NN	I-NP	O
gain	gain	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
reported	report	VBD	B-VP	O
about	about	IN	B-NP	O
35	35	CD	I-NP	O
lb	lb	NN	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Limen	Limen	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
ambulating	ambulate	VBG	I-VP	O
,	,	,	O	O
but	but	CC	O	O
became	become	VBD	B-VP	O
extremely	extremely	RB	B-ADJP	O
short	short	JJ	I-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
took	take	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
what	what	WP	B-NP	O
they	they	PRP	B-NP	O
thought	think	VBD	B-VP	O
was	be	VBD	B-VP	O
primary	primary	JJ	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
process	process	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
they	they	PRP	B-NP	O
noted	note	VBD	B-VP	O
increasing	increase	VBG	B-NP	O
GGTs	GGT	NNS	I-NP	B-protein
without	without	IN	B-PP	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
laboratory	laboratory	NN	I-NP	O
panel	panel	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
rule	rule	NN	I-NP	O
out	out	RP	B-PRT	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
protocol	protocol	NN	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
ruled	rule	VBN	I-VP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
non	non	JJ	I-NP	B-DNA
Q	Q	NN	I-NP	I-DNA
wave	wave	VBP	B-VP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
CKs	CK	NNS	B-NP	B-protein
of	of	IN	B-PP	O
235	235	CD	B-NP	O
,	,	,	O	O
6.3	6.3	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
246	246	CD	B-NP	O
,	,	,	O	O
7.7	7.7	CD	B-NP	O
%	%	NN	I-NP	O
MBs	MB	NNS	I-NP	O
and	and	CC	O	O
197	197	CD	B-NP	O
,	,	,	O	O
7.6	7.6	CD	B-NP	O
%	%	NN	I-NP	O
MBs	MB	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
EKG	EKG	NN	I-NP	B-protein
showed	show	VBD	B-VP	O
anterolateral	anterolateral	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction/ischemic	infarction/ischemic	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
echo	echo	NN	I-NP	O
at	at	IN	B-PP	O
Woodnaw	Woodnaw	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
showed	show	VBD	B-VP	O
decreased	decrease	VBN	B-NP	O
LV	LV	NN	I-NP	O
function	function	NN	I-NP	O
per	per	IN	B-PP	O
report	report	NN	B-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
admission	admission	NN	B-NP	O
there	there	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
repeated	repeat	VBN	I-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain/abdominal	pain/abdominal	JJ	I-NP	O
discomfort	discomfort	NN	I-NP	O
from	from	IN	B-PP	O
7/11/96	7/11/96	CD	B-NP	O
to	to	TO	B-PP	O
5/25/96	5/25/96	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Middvail	Middvail	NNP	I-NP	O
Fredhot	Fredhot	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Mild	Mild	NNP	B-NP	O
mental	mental	JJ	I-NP	O
retardation	retardation	NN	I-NP	O
,	,	,	O	O
schizophrenia	schizophrenia	NN	B-NP	O
,	,	,	O	O
borderline	borderline	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
thyroid	thyroid	JJ	B-NP	O
problems	problem	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
family	family	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
family	family	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
sister	sister	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
daughters	daughter	NNS	I-NP	O
are	be	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
include	include	VBP	B-VP	O
family	family	NN	B-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
borderline	borderline	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
or	or	CC	I-VP	O
drink	drink	VB	I-VP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
dry	dry	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
and	and	CC	I-NP	O
JVP	JVP	NN	I-NP	B-protein
were	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
body	body	NN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
IJ	IJ	NN	I-NP	O
catheter	catheter	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
distant	distant	JJ	B-NP	O
heart	heart	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
without	without	IN	B-PP	O
murmurs	murmur	NNS	B-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	B-protein
had	have	VBD	B-VP	I-protein
crackles	crackle	NNS	B-NP	I-protein
1/4	1/4	CD	B-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
up	up	RP	B-PRT	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
was	be	VBD	B-VP	O
markedly	markedly	RB	B-ADJP	O
obese	obese	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-VP	O
deep	deep	VB	I-VP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
edema	edema	NN	B-NP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
feet	foot	NNS	I-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
abdominal	abdominal	JJ	I-NP	O
canis	canis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
4	4	CD	B-NP	I-protein
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
hips	hip	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
DP	DP	NN	I-NP	O
and	and	CC	I-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

Femoral	Femoral	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
times	time	NNS	B-NP	O
three	three	CD	B-NP	O
and	and	CC	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
understand	understand	VB	I-VP	O
questions	question	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
verbal	verbal	JJ	B-NP	O
skills	skill	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
SMA-20	SMA-20	NN	B-NP	B-protein
and	and	CC	I-NP	O
CBC	CBC	NN	I-NP	B-protein
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
LDH	LDH	NN	I-NP	B-protein
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
at	at	IN	B-PP	O
419	419	CD	B-NP	O
,	,	,	O	O
alkaline	alkaline	NN	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
746	746	CD	B-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
protein	protein	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
at	at	IN	B-PP	O
6.4	6.4	CD	B-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
at	at	IN	B-PP	O
3.6	3.6	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
digoxin	digoxin	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
0.4	0.4	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PTT	PTT	NN	I-NP	O
of	of	IN	B-PP	O
58.8	58.8	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
of	of	IN	B-PP	O
89	89	CD	B-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
R	R	NN	I-NP	O
wave	wave	NN	I-NP	O
progression	progression	NN	I-NP	O
,	,	,	O	O
old	old	JJ	B-NP	O
ischemic	ischemic	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
V5-V6	V5-V6	NN	B-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NNP	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
report	report	NN	B-NP	O
from	from	IN	B-PP	O
Noxer	Noxer	NNP	B-NP	O
Kingsnew	Kingsnew	NNP	I-NP	O
Tesbucks	Tesbucks	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Of	Of	NNP	I-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
mild	mild	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
venous	venous	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
,	,	,	O	O
elevated	elevate	VBD	B-VP	O
right	right	JJ	B-NP	O
hemidiaphragm	hemidiaphragm	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
severely	severely	RB	B-NP	O
dilated	dilate	VBN	I-NP	O
heart	heart	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
contemplated	contemplate	VBN	I-VP	O
to	to	TO	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
ischemia	ischemia	NN	B-NP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
catheterization	catheterization	NN	B-NP	O
would	would	MD	B-VP	O
likely	likely	RB	I-VP	O
require	require	VB	I-VP	O
intubation	intubation	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
sedation	sedation	NN	B-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
psych	psych	NN	I-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
pursue	pursue	VB	I-VP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
conservative	conservative	JJ	I-NP	O
course	course	NN	I-NP	O
with	with	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
medication	medication	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
aggressively	aggressively	RB	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
,	,	,	O	O
Ace	Ace	NNP	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
get	get	VB	I-VP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
b.i.d.	b.i.d.	CC	O	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-NP	O
while	while	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
after	after	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
edema	edema	NN	I-NP	O
slowly	slowly	RB	B-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
breathing	breathing	NN	I-NP	O
improved	improve	VBD	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
ambulate	ambulate	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lost	lose	VBD	B-VP	O
approximately	approximately	RB	B-NP	O
8	8	CD	I-NP	O
kg	kg	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
second	second	JJ	I-NP	O
issue	issue	NN	I-NP	O
was	be	VBD	B-VP	O
gastrointestinal	gastrointestinal	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
,	,	,	O	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
LDH	LDH	NN	I-NP	O
and	and	CC	I-NP	O
alkaline	alkaline	NN	I-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
transaminases	transaminase	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
passive	passive	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
them	them	PRP	B-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
eventually	eventually	RB	B-ADVP	O
drifted	drift	VBD	B-VP	O
down	down	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
elevations	elevation	NNS	I-NP	O
were	be	VBD	B-VP	O
never	never	RB	B-ADVP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
checked	check	VBD	B-VP	O
the	the	DT	B-NP	O
ammonia	ammonia	NN	I-NP	O
level	level	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
and	and	CC	O	O
a	a	DT	B-NP	O
sedimentation	sedimentation	NN	I-NP	O
rate	rate	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
third	third	JJ	I-NP	O
issue	issue	NN	I-NP	O
was	be	VBD	B-VP	O
Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
report	report	NN	B-NP	O
at	at	IN	B-PP	O
Ymont	Ymont	NNP	B-NP	O
Taplaeast	Taplaeast	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
10-15	10-15	CD	I-NP	O
E.coli	E.coli	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
repeated	repeat	VBD	B-VP	O
the	the	DT	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
here	here	RB	B-ADVP	O
and	and	CC	O	O
began	begin	VBD	B-VP	O
ampicillin	ampicillin	NN	B-NP	O
on	on	IN	B-PP	O
p.o.	p.o.	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
10	10	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
was	be	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
limited	limited	JJ	B-NP	O
ambulation	ambulation	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
fourth	fourth	JJ	I-NP	O
issue	issue	NN	I-NP	O
was	be	VBD	B-VP	O
fluids	fluid	NNS	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nutrition	nutrition	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
total	total	JJ	B-NP	O
body	body	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
anasarca	anasarca	NN	I-NP	O
with	with	IN	B-PP	O
slightly	slightly	RB	B-NP	O
decreased	decrease	VBN	I-NP	O
protein	protein	NN	I-NP	O
and	and	CC	I-NP	O
albumin	albumin	NN	I-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
were	be	VBD	B-VP	O
dry	dry	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
felt	feel	VBD	B-VP	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
breathing	breathing	NN	I-NP	O
and	and	CC	I-NP	O
possible	possible	JJ	I-NP	O
intervascular	intervascular	JJ	I-NP	O
depletion	depletion	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
issues	issue	NNS	I-NP	O
cleared	clear	VBD	B-VP	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
fifth	fifth	JJ	I-NP	O
issue	issue	NN	I-NP	O
was	be	VBD	B-VP	O
psych	psych	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
contacted	contact	VBD	B-VP	O
her	her	PRP$	B-NP	O
family	family	NN	I-NP	O
for	for	IN	B-PP	O
support	support	NN	B-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
once	once	RB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
around	around	RP	B-PRT	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Elavil	Elavil	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
ECASA	ECASA	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Cogentin	Cogentin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Haldol	Haldol	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.day	q.day	NN	I-NP	O
,	,	,	O	O
Ativan	Ativan	NNP	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
lisinopril	lisinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
NATHANIEL	NATHANIEL	NNP	B-NP	O
P.	P.	NNP	I-NP	O
DOBBE	DOBBE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
UC46	UC46	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TY	TY	NNP	B-NP	O
P.	P.	NNP	I-NP	O
SCHOENING	SCHOENING	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
ML06	ML06	NNP	I-NP	O
HW629/0178	HW629/0178	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
04471	04471	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

Z5FTIN4HFG	Z5FTIN4HFG	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
1/2/96	1/2/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/25/96	8/25/96	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

SUMSION	SUMSION	NN	B-NP	O
,	,	,	O	O
ALONZO	ALONZO	NNP	B-NP	O
THERON	THERON	NNP	I-NP	O
H.	H.	NNP	I-NP	O
ML06	ML06	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

GORDEY	GORDEY	NNP	B-NP	O
Ralla	Ralla	NNP	I-NP	O
,	,	,	O	O
Arizona	Arizona	NNP	B-NP	O
99514	99514	CD	I-NP	O

